Structure (Image 01)
Mycophenolate Mofetil Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-386
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 67457-386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton 500 mg (Image 02)
Each vial contains 500 mg of mycophenolate mofeti, USP equivalent to 542 mg of mycophenolate moeti hydrochioride. The drug is provided as a powder for injection and must be reconstituted with 14 mL 5% Dexrose Injection, USP. Further dilution of the content of the reconstituted vials with 5% Dextrose Inection, USP is required to produce the infusion solution at the final concentration of 6 mg/mL. Usual dosage and storage conditions are specified. The drug is manufactured by Mylan Institutional LLC and is for intravenous infusion only. Dispense the accompanying Medication Guide to each patient. The expiry date and lot number details are also given.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
